title: Characterization of a new member of the TNF family expressed on antigen presenting cells.
abstract: The TNF family is involved in the regulation of the immune system, and its members have been implicated in a variety of biological events such as apoptosis, cell proliferation, differentiation and survival. Here we present a new member of the TNF family, tumor necrosis factor superfamily member 20 (TNFSF20) that we have identified from the expressed sequence tag (EST) database and characterized. The human protein is a 285 amino acid long type II transmembrane protein and is 19% homologous to TNF in its extra-cellular domain. TNFSF20 is expressed at the surface of antigen presenting cells such as cells of the macrophagemonocyte lineage and dendritic cells. After treatment with bacterial lipopolysaccharide (LPS), TNFSF20 expression is downregulated at the surface of the expresssing cells, suggesting that the membrane-bound protein gets cleaved, and that a soluble factor is released in the extra-cellular compartment. The soluble form of the recombinant TNFSF20 induces proliferation of resting peripheral blood monocytes (PBMC) and cell death of activated lymphocytes. TNFSF20 might therefore play a critical role in the regulation of cell-mediated immune responses.
authors.affiliation: Chiron Corporation, Emeryville, CA 94608-2916, USA.
authors.forename: C
authors.initials: C
authors.lastname: Tribouley
authors.forename: M
authors.initials: M
authors.lastname: Wallroth
authors.forename: V
authors.initials: V
authors.lastname: Chan
authors.forename: X
authors.initials: X
authors.lastname: Paliard
authors.forename: E
authors.initials: E
authors.lastname: Fang
authors.forename: G
authors.initials: G
authors.lastname: Lamson
authors.forename: D
authors.initials: D
authors.lastname: Pot
authors.forename: J
authors.initials: J
authors.lastname: Escobedo
authors.forename: L T
authors.initials: LT
authors.lastname: Williams
mesh_terms: D000595:Amino Acid Sequence; D000818:Animals; D000938:Antigen-Presenting Cells / Q000187:drug effects / Q000378:metabolism*; D053264:B-Cell Activating Factor; D002874:Chromosome Mapping; D018076:DNA, Complementary; D005434:Flow Cytometry; D006801:Humans; D007150:Immunohistochemistry; D008565:Membrane Proteins / Q000235:genetics* / Q000494:pharmacology; D008969:Molecular Sequence Data; D012333:RNA, Messenger / Q000235:genetics; D011994:Recombinant Proteins / Q000494:pharmacology; D014409:Tumor Necrosis Factor-alpha / Q000235:genetics* / Q000494:pharmacology
chemical_list: D053264:B-Cell Activating Factor; D018076:DNA, Complementary; D008565:Membrane Proteins; D012333:RNA, Messenger; D011994:Recombinant Proteins; C505719:TNFSF13B protein, human; D014409:Tumor Necrosis Factor-alpha